{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T09:31:33Z","timestamp":1709458293455},"reference-count":36,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opin. Drug Metab. Toxicol."],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1517\/17425225.3.4.621","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T13:34:37Z","timestamp":1187098477000},"page":"621-631","source":"Crossref","is-referenced-by-count":1,"title":["Clopidogrel: an updated and comprehensive review"],"prefix":"10.1517","volume":"3","author":[{"given":"Keith AA","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Chelliah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"ref-1_1","first-page":"145","volume":"11","author":"HOLLOPETER","year":"2001","journal-title":"Nature"},{"key":"ref-2_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","volume":"321","author":"HASS","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref-3_3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703761"},{"key":"ref-4_4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00761-6"},{"key":"ref-5_5","doi-asserted-by":"publisher","DOI":"10.1136\/heart.85.1.92"},{"key":"ref-6_6","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01453.x"},{"key":"ref-7_7","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00470-6"},{"key":"ref-8_8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000112378.09325.F9"},{"key":"ref-9_9","first-page":"IV","volume":"108","author":"SAUCEDO","year":"2003","journal-title":"Circulation"},{"key":"ref-10_10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000099507.32936.C0"},{"key":"ref-11_11","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.18.2051"},{"key":"ref-12_12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"ref-13_13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"ref-14_14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140675.85342.1B"},{"key":"ref-15_15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050522"},{"key":"ref-16_16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67660-X"},{"key":"ref-17_17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05701-4"},{"key":"ref-18_18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.10.1224"},{"key":"ref-19_19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2411"},{"key":"ref-20_20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)10285-X"},{"key":"ref-21_21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382102"},{"key":"ref-22_22","first-page":"A6","volume":"12","author":"WHITE","year":"2000","journal-title":"J. Invas. Cardiol."},{"key":"ref-23_23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07442-1"},{"key":"ref-24_24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.joc60034"},{"key":"ref-25_25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60450-4"},{"key":"ref-26_26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060989"},{"key":"ref-27_27","unstructured":"BHATT DL, FLATHER MD, HACKE Wet al.: Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.J. Am. Coll. Cardiol.(2007 )49:1982 -1988."},{"key":"ref-28_28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.04.012"},{"key":"ref-29_29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.502815"},{"key":"ref-30_30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.18.1992"},{"key":"ref-31_31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.18.2001"},{"key":"ref-32_32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.18.2028"},{"key":"ref-33_33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7438.477"},{"key":"ref-34_34","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm161"},{"key":"ref-35_35","unstructured":"NATIONAL COLLABORATING CENTRE FOR PRIMARY CARE: NICE clinical guideline 48 MI: secondary prevention (2007 )."},{"key":"ref-36_36","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0297"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"deposited":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T21:58:47Z","timestamp":1497736727000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.expertopin.com\/doi\/abs\/10.1517\/17425225.3.4.621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1517\/17425225.3.4.621"],"URL":"https:\/\/doi.org\/10.1517\/17425225.3.4.621","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}